Home / Drugs / Hepatitis B Vaccine (Recombinant) Adjuvanted

Hepatitis B Vaccine (Recombinant) Adjuvanted

FDA Drug Profile — HEPLISAV-B

Drug Details

Generic Name: Hepatitis B Vaccine (Recombinant) Adjuvanted
Brand Names: HEPLISAV-B
Application Number: BLA125428
Sponsor: Dynavax Technologies Corporation
NDC Codes: 2
Dosage Forms: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Active Ingredients: HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN